English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45279/58455 (77%)
造訪人次 : 2488368      線上人數 : 160
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/44685


    題名: Increased Risk of Adverse Pregnancy Outcomes in Women Receiving Zolpidem During Pregnancy
    作者: Wang,L-H;林秀真;Lin,C-C;Chen,Y-H;Lin,H-C
    貢獻者: 臺北醫大學附設醫院
    關鍵詞: Adverse Pregnancy;Zolpidem During
    日期: 2010-08-04
    上傳時間: 2012-01-17 15:14:33 (UTC+8)
    摘要: This nationwide population-based study was carried out in Taiwan with the aim of comparing the risk of adverse
    pregnancy outcomes in women who received zolpidem treatment for insomnia during pregnancy with that in women
    who did not. The adverse outcomes identified and assessed were delivery of low-birth-weight (LBW) infants, preterm
    deliveries, delivery of small-for-gestational-age (SGA) infants, delivery of infants with congenital anomalies, and cesarean
    delivery. The incidences of these were compared between the groups after adjusting for other characteristics of the
    mothers and infants. The study used the Taiwan National Health Insurance Research Dataset (NHIRD) and birth-certificate
    registry. In total, the data from 2,497 mothers who received zolpidem treatment during pregnancy and those from
    12,485 randomly selected mothers who did not receive the drug were included in the analysis. The results show that the
    adjusted odds ratios (ORs) for adverse pregnancy outcomes—LBW infants, preterm deliveries, SGA infants, and cesarean
    delivery—were all higher in mothers who received zolpidem treatment during pregnancy, relative to the randomly
    selected controls (1.39 (95% confidence interval (CI) = 1.17–1.64), 1.49 (95% CI = 1.28–1.74), 1.34 (95% CI = 1.20–1.49),
    and 1.74 (95% CI = 1.59–1.90), respectively). In conclusion, the risk of adverse pregnancy outcomes was higher in women
    who received zolpidem during pregnancy than in those who did not.
    關聯: Clinical pharmacology and therapeutics. 88(3): 369-374.
    顯示於類別:[小兒學科] 期刊論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    Increased Risk of Adverse Pregnancy Outcomes in Women Receiving Zolpidem During Pregnancy0KbHTML83檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋